Hansa Medical shares gain on good kidney transplant drug news

LONDON (Reuters) - Shares in Sweden's Hansa Medical jumped 12 percent on Thursday after research showed its experimental drug allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news